SML3630

MK-0159

≥98% (HPLC)

• Synonyme(s) : MK 0159, MK0159, N-((1r,4r)-4-(2-Methoxyethoxy)cyclohexyl)-6-(thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide, N-[trans-4-(2-Methoxyethoxy)cyclohexyl]-6-(5-thiazolyl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide
• Formule empirique (notation de Hill) : C₂₀H₂₄N₄O₃S
• Numéro CAS: 2641484-61-7
• Poids moléculaire : 400.49
• UNSPSC Code: 12352200
• NACRES: NA.77
• Assay: ≥98% (HPLC)
• Form: powder

Propriétés

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: O=C(C1=C2C(NC=C2)=NC(C3=CN=CS3)=C1)N[C@H]4CC[C@@H](CC4)OCCOC
• InChI key: JUVJFMVGYBBDKN-HDJSIYSDSA-N

Description

Biochem/physiol Actions

MK-0159 is an orally active, potent and selective CD38 inhibitor (h/m/r CD38 IC50 = 22/3/70 nM) that increases extra- and intracellular NAD+ levels in high CD38-expressing human epithelial A549 cultures, as well as intracellular NAD+/NADP+ in HMVECs (0.3-50 µM). MK-0159 (3-30 mg/kg p.o.) increases systemic NAD+ and decreases ADPR levels in mice, providing protection from myocardial damage upon cardiac I/R injury in vivo (30 mg/kg p.o.).

Potent and selective CD38 inhibitor that protects mice from myocardial damage upon cardiac I/R injury in vivo.

Informations sur la sécurité

• Classe de stockage: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable